H
Haruo Sakamoto
Researcher at Tokai University
Publications - 60
Citations - 508
Haruo Sakamoto is an academic researcher from Tokai University. The author has contributed to research in topics: Odontogenic infection & Neck dissection. The author has an hindex of 10, co-authored 59 publications receiving 446 citations.
Papers
More filters
Journal ArticleDOI
Analysis of risk factors for surgical-site infections in 276 oral cancer surgeries with microvascular free-flap reconstructions at a single university hospital
Kazunari Karakida,Takayuki Aoki,Yoshihide Ota,Hiroshi Yamazaki,Mitsunobu Otsuru,Miho Takahashi,Haruo Sakamoto,Muneo Miyasaka +7 more
TL;DR: The purpose of this study was to elucidate the risk factors for surgical-site infection (SSI) in oral cancer surgery with microvascular free-flap reconstructions and to propose appropriate SSI prevention.
Journal ArticleDOI
Descending necrotizing mediastinitis due to odontogenic infections
TL;DR: The importance of early diagnosis, aggressive surgical intervention, and optimal antibiotics chemotherapy in controlling this fatal infectious disease, termed descending necrotizing mediastinitis, is shown.
Journal ArticleDOI
Isolation of bacteria from cervical lymph nodes in patients with oral cancer.
Haruo Sakamoto,Hiroyuki Naito,Yoshihide Ohta,Rin Tanakna,Nobuko Maeda,Jiro Sasaki,Carl Erik Nord +6 more
TL;DR: Damaged oral mucosa in patients with oral cancer might allow the new bacterial colonization on the surface and subsequently drain the bacteria into the regional lymph nodes as well as the general circulation.
Journal ArticleDOI
Ameloblastic carcinoma, secondary type: a case report.
Kazunari Karakida,Takayuki Aoki,Haruo Sakamoto,Miho Takahashi,Tadashi Akamatsu,Go Ogura,Yasutomo Sekido,Yoshihide Ota +7 more
TL;DR: A rare case of ameloblastic carcinoma is experienced, secondary type which might arise in an untreated ameloblastoma, which is classified into 2 types: a primary odontogenic malignancy and a secondary type resulting from malignant transformation of a primary lesion.
Journal ArticleDOI
Premedication with cyclooxygenase-2 inhibitor meloxicam reduced postoperative pain in patients after oral surgery
Takayuki Aoki,H. Yamaguchi,Hiroyuki Naito,Kazuo Shiiki,K. Izawa,Yoshihide Ota,Haruo Sakamoto,Akihiro Kaneko +7 more
TL;DR: The COX-2 inhibitor, meloxicam 10 mg used for premedication reduced postoperative pain compared with control in oral surgery, and the total analgesic consumption was significantly lower in groups A and B than in group C.